1887

Abstract

The Towne strain of human cytomegalovirus (HCMV), originally recovered from the urine of a congenitally infected newborn, was attenuated through 125 passages in human embryonic lung fibroblast cell cultures. Although reliable markers of attenuation were not identified, the virus was shown to be attenuated by inoculation of both healthy human volunteers and immunocompromised patients. More recently, Towne (like other laboratory-adapted strains) was shown not to have two biological properties typical of recent clinical isolates: endothelial cell tropism and polymorphonuclear leukocyte tropism. These markers of attenuation are lost by all clinical isolates on extensive propagation in cell cultures and are apparently associated with one another. Here, we show that Towne may reacquire both endothelial cell tropism and leuko- (polymorphonuclear- and monocyte-) tropism on adaptation to growth in endothelial cell cultures. However, reversion to endothelial cell tropism is dissociated from reversion to leukotropism, since the latter was reacquired 10–20 passages later. Thus, these two biological properties, which were considered to be encoded by the same viral gene(s), appear to be distinct. Both restriction fragment length polymorphism and Southern blot analysis demonstrated the identity of the attenuated and endothelial cell tropic variants of Towne, thus suggesting that only minor variations (mutations) of the viral genome may be responsible for loss or reacquisition of the two biological properties. Viral genes involved in endothelial cell tropism and leukotropism remain to be identified. However, reversion of attenuated strains to pathogenicity cannot be excluded .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-8-1993
2002-08-01
2019-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/8/0831993a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-8-1993&mimeType=html&fmt=ahah

References

  1. Fish, K. N., Depto, A. S., Moses, A. V., Britt, W. & Nelson, J. A. ( 1995; ). Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. Journal of Virology 69, 3737-3743.
    [Google Scholar]
  2. Fish, K. N., Britt, W. & Nelson, J. A. ( 1996; ). A novel mechanism for persistence of human cytomegalovirus in macrophages. Journal of Virology 70, 1855-1862.
    [Google Scholar]
  3. Fleisher, G. R., Starr, S. E., Friedman, H. M. & Plotkin, S. A. ( 1982; ). Vaccination of pediatric nurses with live attenuated cytomegalovirus. American Journal of Diseases of Children 136, 294-296.
    [Google Scholar]
  4. Gerna, G., Revello, M. G., Percivalle, E., Zavattoni, M., Parea, M. & Battaglia, M. ( 1990; ). Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. Journal of Clinical Microbiology 28, 2681-2688.
    [Google Scholar]
  5. Gerna, G., Revello, M. G., Percivalle, E. & Morini, F. ( 1992; ). Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology 30, 1232-1237.
    [Google Scholar]
  6. Gerna, G., Percivalle, E., Torsellini, M. & Revello, M. G. ( 1998a; ). Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. Journal of Clinical Microbiology 36, 3585-3589.
    [Google Scholar]
  7. Gerna, G., Zavattoni, M., Baldanti, F., Sarasini, A., Chezzi, L., Grossi, P. & Revello, M. G. ( 1998b; ). Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 65, 1378-1385.[CrossRef]
    [Google Scholar]
  8. Gerna, G., Percivalle, E., Baldanti, F., Sozzani, S., Lanzarini, P., Genini, E., Lilleri, D. & Revello, M. G. ( 2000; ). Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. Journal of Virology 74, 5629-5638.[CrossRef]
    [Google Scholar]
  9. Gerna, G., Percivalle, E., Baldanti, F. & Revello, M. G. ( 2002a; ). Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. Journal of Medical Virology 66, 335-339.[CrossRef]
    [Google Scholar]
  10. Gerna, G., Percivalle, E., Sarasini, A. & Revello, M. G. ( 2002b; ). Human cytomegalovirus and human umbilical vein endothelial cells: restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation. Journal of Clinical Microbiology 40, 233-238.[CrossRef]
    [Google Scholar]
  11. Grundy, J. E., Lawson, K. M., MacCormac, L. P., Fletcher, J. M. & Yong, K. L. ( 1998; ). Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. Journal of Infectious Diseases 177, 1465-1474.[CrossRef]
    [Google Scholar]
  12. Ibanez, C. E., Schrier, R., Ghazal, P., Wiley, C. & Nelson, J. A. ( 1991; ). Human cytomegalovirus productively infects primary differentiated macrophages. Journal of Virology 65, 6581-6588.
    [Google Scholar]
  13. Lathey, J. L. & Spector, S. A. ( 1991; ). Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. Journal of Virology 65, 6371-6375.
    [Google Scholar]
  14. Plotkin, S. A., Furukawa, T., Zygraich, N. & Huygelen, C. ( 1975; ). Candidate cytomegalovirus strain for human vaccination. Infection and Immunity 12, 521-527.
    [Google Scholar]
  15. Plotkin, S. A., Farquhar, J. & Hornberger, E. ( 1976; ). Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. Journal of Infectious Diseases 134, 470-475.[CrossRef]
    [Google Scholar]
  16. Plotkin, S. A., Starr, S. E., Friedman, H. M., Gönczöl, E. & Weibel, R. E. ( 1989; ). Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. Journal of Infectious Diseases 159, 860-865.[CrossRef]
    [Google Scholar]
  17. Quinnan, G. V.Jr, Delery, M., Rook, A. H., Frederick, W. R., Epstein, J. S., Manischewitz, J. F., Jackson, L., Ramsey, K. M., Mittal, K., Plotkin, S. A. & Hilleman, M. R. ( 1984; ). Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Annals of Internal Medicine 101, 478-483.[CrossRef]
    [Google Scholar]
  18. Revello, M. G., Percivalle, E., Arbustini, E., Pardi, R., Sozzani, S. & Gerna, G. ( 1998; ). In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. Journal of Clinical Investigation 101, 2686-2692.[CrossRef]
    [Google Scholar]
  19. Revello, M. G., Baldanti, F., Percivalle, E., Sarasini, A., De Giuli, L., Genini, E., Lilleri, D., Labò, N. & Gerna, G. ( 2001; ). In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. Journal of General Virology 82, 1429-1438.
    [Google Scholar]
  20. Söderberg, C., Larsson, S., Bergstedt-Lindqvist, S. & Möller, E. ( 1993; ). Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. Journal of Virology 67, 3166-3175.
    [Google Scholar]
  21. Söderberg-Nauclér, C., Fish, K. N. & Nelson, J. A. ( 1997; ). Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126.[CrossRef]
    [Google Scholar]
  22. Söderberg-Nauclér, C., Streblow, D. N., Fish, K. N., Allan-Yorke, J., Smith, P. P. & Nelson, J. A. ( 2001; ). Reactivation of latent human cytomegalovirus in CD14+ monocytes is differentiation dependent. Journal of Virology 75, 7543-7554.[CrossRef]
    [Google Scholar]
  23. Taylor-Wiedeman, J., Sissons, J. G., Borysiewicz, L. K. & Sinclair, J. H. ( 1991; ). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. Journal of General Virology 72, 2059-2064.[CrossRef]
    [Google Scholar]
  24. Taylor-Wiedeman, J., Sissons, P. & Sinclair, J. ( 1994; ). Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. Journal of Virology 68, 1597-1604.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-8-1993
Loading
/content/journal/jgv/10.1099/0022-1317-83-8-1993
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error